MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2006 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
1.24 M |
Marktkapitalisierung |
$ 820 K |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
EyePoint Pharmaceuticals
EYPT
|
$ 3.25 | 0.62 % | $ 238 K | Nasdaq Global Market | USA |
 |
Fate Therapeutics
FATE
|
$ 2.32 | 0.87 % | $ 276 M | Nasdaq Global Market,SPB | USA |
 |
Fortress Biotech
FBIO
|
$ 2.03 | 0.83 % | $ 56.6 M | Nasdaq Capital Market | USA |
 |
Fennec Pharmaceuticals
FENC
|
$ 10.2 | 0.29 % | $ 291 M | Nasdaq Capital Market | USA |
 |
Foghorn Therapeutics
FHTX
|
$ 2.02 | 1.42 % | $ 127 M | Nasdaq Global Market | USA |
 |
Fulcrum Therapeutics
FULC
|
$ 3.69 | 0.27 % | $ 234 M | Nasdaq Global Market | USA |
 |
Galectin Therapeutics
GALT
|
$ 3.9 | 3.72 % | $ 249 M | Nasdaq Global Select Market | USA |
 |
Geron Corporation
GERN
|
$ 1.2 | 0.41 % | $ 800 M | Nasdaq Global Select Market | USA |
 |
Gilead Sciences
GILD
|
$ 144.74 | 0.85 % | $ 180 B | Nasdaq Global Select Market,SPB | USA |
 |
Greenwich LifeSciences
GLSI
|
$ 16.98 | 0.12 % | $ 230 M | Nasdaq Capital Market | USA |
 |
Genmab A/S
GMAB
|
$ 34.75 | 0.58 % | $ 2.25 B | Nasdaq Global Select Market |  Danmark |
 |
Genprex
GNPX
|
$ 2.63 | 2.73 % | $ 2.45 M | Nasdaq Capital Market | USA |
 |
Gossamer Bio
GOSS
|
$ 10.71 | 0.37 % | $ 2.45 B | Nasdaq Global Select Market,SPB | USA |
 |
GeoVax Labs
GOVX
|
$ 0.32 | 1.89 % | $ 307 K | Nasdaq Global Select Market | USA |
 |
Grifols, S.A.
GRFS
|
$ 7.31 | 0.14 % | $ 4.97 B | Nasdaq Global Select Market |  Spain |
 |
GlaxoSmithKline plc
GSK
|
$ 47.03 | 0.93 % | $ 191 B | NYSE |  Britain |
 |
GT Biopharma
GTBP
|
$ 6.1 | 0.08 % | $ 33.6 M | Nasdaq Capital Market | USA |
 |
Halozyme Therapeutics
HALO
|
$ 109.86 | 2.73 % | $ 13.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Hutchison China MediTech Limited
HCM
|
$ 14.2 | 0.03 % | $ 12.2 B | Nasdaq Global Select Market |  China |
 |
Harmony Biosciences Holdings
HRMY
|
$ 39.64 | 0.18 % | $ 2.28 B | Nasdaq Global Select Market | USA |
 |
Heron Therapeutics
HRTX
|
$ 0.35 | 1.99 % | $ 58.3 M | Nasdaq Global Select Market,SPB | USA |
 |
iBio
IBIO
|
$ 1.13 | 1.35 % | $ 118 M | NYSE American | USA |
 |
ImmuCell Corporation
ICCC
|
$ 9.75 | 1.56 % | $ 88 M | Nasdaq Global Select Market | USA |
 |
IDEAYA Biosciences
IDYA
|
$ 37.36 | 1.11 % | $ 3.31 B | Nasdaq Global Select Market | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.72 | 0.58 % | $ 116 M | Nasdaq Global Select Market |  Germany |
 |
Inhibikase Therapeutics
IKT
|
$ 2.0 | 3.63 % | $ 197 M | Nasdaq Capital Market | USA |
 |
Immutep Limited
IMMP
|
$ 4.35 | 0.21 % | $ 6.33 B | Nasdaq Global Market |  Australia |
 |
Immunome
IMNM
|
$ 20.9 | 0.05 % | $ 1.83 B | Nasdaq Global Select Market | USA |
 |
Immuron Limited
IMRN
|
$ 1.09 | 2.59 % | $ 252 M | Nasdaq Global Select Market | Australia |
|
Immatics N.V.
IMTX
|
$ 7.59 | 0.17 % | $ 929 M | Nasdaq Global Select Market | Germany |
 |
Immunic
IMUX
|
$ 7.96 | 4.38 % | $ 1.24 B | Nasdaq Global Select Market | USA |
 |
Immunovant
IMVT
|
$ 33.62 | 0.3 % | $ 6.13 B | Nasdaq Global Select Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Inhibrx
INBX
|
$ 96.99 | 0.5 % | $ 4.57 B | Nasdaq Global Select Market | USA |
 |
Incyte Corporation
INCY
|
$ 115.3 | 0.06 % | $ 22.5 B | Nasdaq Global Select Market,SPB | USA |
 |
InMed Pharmaceuticals
INM
|
$ 1.33 | 0.37 % | $ 5.54 M | Nasdaq Capital Market |  Canada |
 |
INmune Bio
INMB
|
$ 1.93 | 0.52 % | $ 47.8 M | Nasdaq Capital Market | USA |
 |
Inovio Pharmaceuticals
INO
|
$ 1.16 | 2.05 % | $ 54.4 M | Nasdaq Global Select Market | USA |
 |
Insmed Incorporated
INSM
|
$ 111.12 | 2.33 % | $ 22.1 B | Nasdaq Global Select Market | USA |
 |
Ionis Pharmaceuticals
IONS
|
$ 43.54 | 0.13 % | $ 6.97 B | Nasdaq Global Select Market,SPB | USA |
 |
Iovance Biotherapeutics
IOVA
|
$ 14.22 | 0.6 % | $ 5.08 M | Nasdaq Global Market,SPB | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.56 | 0.63 % | $ 140 M | Nasdaq Global Select Market |  France |
 |
Ironwood Pharmaceuticals
IRWD
|
$ 3.64 | 0.27 % | $ 589 M | Nasdaq Global Select Market | USA |
 |
Inventiva S.A.
IVA
|
$ 3.56 | 2.89 % | $ 213 M | Nasdaq Global Market | France |
 |
Jaguar Health
JAGX
|
$ 3.66 | 1.01 % | $ 8.54 M | Nasdaq Capital Market | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
$ 235.67 | 1.14 % | $ 14.4 B | Nasdaq Global Select Market |  Irlanda |
 |
Johnson & Johnson
JNJ
|
$ 256.03 | 0.03 % | $ 616 B | NYSE,SPB | USA |
 |
Kala Pharmaceuticals
KALA
|
$ 0.39 | 0.86 % | $ 3.18 M | Nasdaq Global Select Market | USA |
 |
Kamada Ltd.
KMDA
|
$ 8.31 | 1.34 % | $ 479 M | Nasdaq Global Select Market |  Israel |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 75.79 | 0.76 % | $ 5.62 B | Nasdaq Global Select Market | USA |